Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Leukemia 4Myelodysplastic Syndromes 2Multiple Myeloma 2Leukemia, Myeloid, Acute 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Lymphoma 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Hodgkin Disease 1Hematologic Neoplasms 1Congenital Abnormalities 1Blast Crisis 1

Interventions

Mycophenolic Acid 8Cyclophosphamide 8fludarabine phosphate 7Cyclosporine 7Peripheral Blood Stem Cell Transplantation 6Filgrastim 6Radiotherapy 5Cord Blood Stem Cell Transplantation 5Busulfan 5Antilymphocyte Serum 5Tacrolimus 4Methylprednisolone 4Methotrexate 3Granulocyte Colony-Stimulating Factor 3Whole-Body Irradiation 2Sunitinib 2Sirolimus 2Moxifloxacin 2Melphalan 2Ipilimumab 2Flow Cytometry 2Etoposide 2CTLA-4 Antigen 2Amplified Fragment Length Polymorphism Analysis 2venetoclax 1trametinib 1thymoglobulin 1sargramostim 1ruxolitinib 1regorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Methylprednisolone Acetate × Clear all
NCT00354172 2017-12-28

Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.

Masonic Cancer Center, University of Minnesota

Phase 2 Terminated
16 enrolled 19 charts
MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡